103 related articles for article (PubMed ID: 20429629)
1. Deleted in breast cancer 1 (DBC1) is a dynamically regulated protein.
Kim JE; Sung S
Neoplasma; 2010; 57(4):365-8. PubMed ID: 20429629
[TBL] [Abstract][Full Text] [Related]
2. Repression of estrogen receptor beta function by putative tumor suppressor DBC1.
Koyama S; Wada-Hiraike O; Nakagawa S; Tanikawa M; Hiraike H; Miyamoto Y; Sone K; Oda K; Fukuhara H; Nakagawa K; Kato S; Yano T; Taketani Y
Biochem Biophys Res Commun; 2010 Feb; 392(3):357-62. PubMed ID: 20074560
[TBL] [Abstract][Full Text] [Related]
3. A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo.
Santos L; Colman L; Contreras P; Chini CC; Carlomagno A; Leyva A; Bresque M; Marmisolle I; Quijano C; Durán R; Irigoín F; Prieto-Echagüe V; Vendelbo MH; Sotelo-Silveira JR; Chini EN; Badano JL; Calliari AJ; Escande C
Sci Rep; 2019 Oct; 9(1):14381. PubMed ID: 31591441
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization, alternative splicing and expression analysis of bovine DBC1.
Li M; Sun X; Hua L; Huang Y; Wang J; Cao X; Zhan Z; Lan X; Chen H
Gene; 2013 Sep; 527(2):689-93. PubMed ID: 23845782
[TBL] [Abstract][Full Text] [Related]
5. Balance between SIRT1 and DBC1 expression is lost in breast cancer.
Sung JY; Kim R; Kim JE; Lee J
Cancer Sci; 2010 Jul; 101(7):1738-44. PubMed ID: 20412117
[TBL] [Abstract][Full Text] [Related]
6. Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through impaired responses to UV-induced DNA damage.
Kim W; Kim JE
Cancer Lett; 2013 Jun; 333(2):180-6. PubMed ID: 23352644
[TBL] [Abstract][Full Text] [Related]
7. A positive role of DBC1 in PEA3-mediated progression of estrogen receptor-negative breast cancer.
Kim HJ; Kim SH; Yu EJ; Seo WY; Kim JH
Oncogene; 2015 Aug; 34(34):4500-8. PubMed ID: 25417701
[TBL] [Abstract][Full Text] [Related]
8. DBC1 is a negative regulator of SIRT1.
Kim JE; Chen J; Lou Z
Nature; 2008 Jan; 451(7178):583-6. PubMed ID: 18235501
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy.
Yu EJ; Kim SH; Heo K; Ou CY; Stallcup MR; Kim JH
Nucleic Acids Res; 2011 Sep; 39(16):6932-43. PubMed ID: 21596782
[TBL] [Abstract][Full Text] [Related]
10. Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma.
Lee H; Kim KR; Noh SJ; Park HS; Kwon KS; Park BH; Jung SH; Youn HJ; Lee BK; Chung MJ; Koh DH; Moon WS; Jang KY
Hum Pathol; 2011 Feb; 42(2):204-13. PubMed ID: 21056897
[TBL] [Abstract][Full Text] [Related]
11. DBC1/CCAR2 and CCAR1 Are Largely Disordered Proteins that Have Evolved from One Common Ancestor.
Brunquell J; Yuan J; Erwin A; Westerheide SD; Xue B
Biomed Res Int; 2014; 2014():418458. PubMed ID: 25610865
[TBL] [Abstract][Full Text] [Related]
12. Identification of DBC1 as a transcriptional repressor for BRCA1.
Hiraike H; Wada-Hiraike O; Nakagawa S; Koyama S; Miyamoto Y; Sone K; Tanikawa M; Tsuruga T; Nagasaka K; Matsumoto Y; Oda K; Shoji K; Fukuhara H; Saji S; Nakagawa K; Kato S; Yano T; Taketani Y
Br J Cancer; 2010 Mar; 102(6):1061-7. PubMed ID: 20160719
[TBL] [Abstract][Full Text] [Related]
13. DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.
Zannini L; Buscemi G; Kim JE; Fontanella E; Delia D
J Mol Cell Biol; 2012 Oct; 4(5):294-303. PubMed ID: 22735644
[TBL] [Abstract][Full Text] [Related]
14. The Proteomic Profile of Deleted in Breast Cancer 1 (DBC1) Interactions Points to a Multifaceted Regulation of Gene Expression.
Giguère SS; Guise AJ; Jean Beltran PM; Joshi PM; Greco TM; Quach OL; Kong J; Cristea IM
Mol Cell Proteomics; 2016 Mar; 15(3):791-809. PubMed ID: 26657080
[TBL] [Abstract][Full Text] [Related]
15. Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma.
Cha EJ; Noh SJ; Kwon KS; Kim CY; Park BH; Park HS; Lee H; Chung MJ; Kang MJ; Lee DG; Moon WS; Jang KY
Clin Cancer Res; 2009 Jul; 15(13):4453-9. PubMed ID: 19509139
[TBL] [Abstract][Full Text] [Related]
16. The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.
Kim SH; Kim JH; Yu EJ; Lee KW; Park CK
Histol Histopathol; 2012 Jan; 27(1):49-58. PubMed ID: 22127596
[TBL] [Abstract][Full Text] [Related]
17. DBC1 functions as a tumor suppressor by regulating p53 stability.
Qin B; Minter-Dykhouse K; Yu J; Zhang J; Liu T; Zhang H; Lee S; Kim J; Wang L; Lou Z
Cell Rep; 2015 Mar; 10(8):1324-34. PubMed ID: 25732823
[TBL] [Abstract][Full Text] [Related]
18. SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1.
Zhang H; Xu Y; Filipovic A; Lit LC; Koo CY; Stebbing J; Giamas G
Br J Cancer; 2013 Nov; 109(10):2675-84. PubMed ID: 24129246
[TBL] [Abstract][Full Text] [Related]
19. Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice.
Escande C; Chini CC; Nin V; Dykhouse KM; Novak CM; Levine J; van Deursen J; Gores GJ; Chen J; Lou Z; Chini EN
J Clin Invest; 2010 Feb; 120(2):545-58. PubMed ID: 20071779
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression.
Liu Q; Luo Q; Feng J; Zhao Y; Ma B; Cheng H; Zhao T; Lei H; Mu C; Chen L; Meng Y; Zhang J; Long Y; Su J; Chen G; Li Y; Hu G; Liao X; Chen Q; Zhu Y
Elife; 2022 Aug; 11():. PubMed ID: 35913115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
